Company intelligence / Profile preview

Virica Biotech

Ottawa, Ontario, Canadaviricabiotech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Virica’s VSEs have been evaluated in over 50 applications across a wide range of cell lines and virus combinations. The company has demonstrated improved viral vector yields for gene therapy and vaccine manufacturers. No clinical results reported as their main business focuses on enabling manufacturing rather than direct patient therapeutics

Therapeutic areas: OtherOncology
Modalities: Small molecule
Industry: Non-Drug Biotech

Partnerships

Collaborations with vaccine manufacturers and pharmaceutical companies to optimize viral vector/vaccine production processesMember of BIOTECanada and Alliance of Regenerative Medicine industry groups

Beyond the preview

Go deeper on Virica Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Virica Biotech.

Explore the full profile